Genome-wide association studies suggest that Myo19 may involve in ovarian cancer, pancreatic ductal adenocarcinoma and breast cancer but whether it may play a tumor suppressive role is unclear62–67. The gene discussed is MYO19; the disease is breast carcinoma.